These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32809146)

  • 1. Urinary soluble CD163 is a good biomarker for renal disease activity in lupus nephritis.
    Gupta R; Yadav A; Aggarwal A
    Clin Rheumatol; 2021 Mar; 40(3):941-948. PubMed ID: 32809146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages.
    Zhang T; Li H; Vanarsa K; Gidley G; Mok CC; Petri M; Saxena R; Mohan C
    Front Immunol; 2020; 11():671. PubMed ID: 32351512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary sCD25 as a biomarker of lupus nephritis disease activity.
    Gupta R; Yadav A; Misra R; Aggarwal A
    Lupus; 2015 Mar; 24(3):273-9. PubMed ID: 25305215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary osteoprotegerin: a potential biomarker of lupus nephritis disease activity.
    Gupta R; Aggarwal A; Sinha S; Rajasekhar L; Yadav A; Gaur P; Misra R; Negi VS
    Lupus; 2016 Oct; 25(11):1230-6. PubMed ID: 26936893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary C3d is elevated in patients with active Lupus nephritis and a fall in its level after 3 months predicts response at 6 months on follow up.
    Ganguly S; Majumder S; Kumar S; Gupta R; Muhammed H; Shobha V; Aggarwal A; Misra R
    Lupus; 2020 Nov; 29(13):1800-1806. PubMed ID: 32807020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal assessment of monocyte chemoattractant protein-1 in lupus nephritis as a biomarker of disease activity.
    Gupta R; Yadav A; Aggarwal A
    Clin Rheumatol; 2016 Nov; 35(11):2707-2714. PubMed ID: 27624649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary soluble CD163 level reflects glomerular inflammation in human lupus nephritis.
    Endo N; Tsuboi N; Furuhashi K; Shi Y; Du Q; Abe T; Hori M; Imaizumi T; Kim H; Katsuno T; Ozaki T; Kosugi T; Matsuo S; Maruyama S
    Nephrol Dial Transplant; 2016 Dec; 31(12):2023-2033. PubMed ID: 27242373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis.
    Mok CC; Soliman S; Ho LY; Mohamed FA; Mohamed FI; Mohan C
    Arthritis Res Ther; 2018 Jan; 20(1):6. PubMed ID: 29325582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.
    Abujam B; Cheekatla S; Aggarwal A
    Lupus; 2013 May; 22(6):614-23. PubMed ID: 23629827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary haptoglobin, alpha-1 anti-chymotrypsin and retinol binding protein identified by proteomics as potential biomarkers for lupus nephritis.
    Aggarwal A; Gupta R; Negi VS; Rajasekhar L; Misra R; Singh P; Chaturvedi V; Sinha S
    Clin Exp Immunol; 2017 May; 188(2):254-262. PubMed ID: 28120479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary soluble CD163 is useful as "liquid biopsy" marker in lupus nephritis at both diagnosis and follow-up to predict impending flares.
    Renaudineau Y; Chauveau D; Faguer S; Huart A; Ribes D; Pugnet G; Sailler L; Jamme T; Treiner E; Fortenfant F; Bost C; Carlé C; Belliere J
    J Transl Autoimmun; 2024 Dec; 9():100244. PubMed ID: 39021518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus.
    Nishino A; Katsumata Y; Kawasumi H; Hirahara S; Kawaguchi Y; Yamanaka H
    Lupus; 2019 Jul; 28(8):986-994. PubMed ID: 31246559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of serum soluble scavenger receptor CD163 in patients with lupus nephritis.
    Liu Y; Li M; Zhang H; Yin Z; Wang X
    Lupus; 2024 Oct; 33(12):1279-1288. PubMed ID: 39172599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary CD163 is a marker of active kidney disease in childhood-onset lupus nephritis.
    Inthavong H; Vanarsa K; Castillo J; Hicks MJ; Mohan C; Wenderfer SE
    Rheumatology (Oxford); 2023 Mar; 62(3):1335-1342. PubMed ID: 35961024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL): potential biomarkers of active lupus nephritis.
    Phatak S; Chaurasia S; Mishra SK; Gupta R; Agrawal V; Aggarwal A; Misra R
    Clin Exp Immunol; 2017 Mar; 187(3):376-382. PubMed ID: 27804111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis.
    Mejia-Vilet JM; Zhang XL; Cruz C; Cano-Verduzco ML; Shapiro JP; Nagaraja HN; Morales-Buenrostro LE; Rovin BH
    J Am Soc Nephrol; 2020 Jun; 31(6):1335-1347. PubMed ID: 32300067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary prostaglandin D synthase as biomarker in lupus nephritis: a longitudinal study.
    Gupta R; Yadav A; Misra R; Aggarwal A
    Clin Exp Rheumatol; 2015; 33(5):694-8. PubMed ID: 26211517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinico-serological associations of urinary activated leukocyte cell adhesion molecule in systemic lupus erythematosus and lupus nephritis.
    Amer AS; Abdel Moneam SM; Hashaad NI; Yousef EM; Abd El-Hassib DM
    Clin Rheumatol; 2024 Mar; 43(3):1015-1021. PubMed ID: 38294724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine ALCAM, PF4 and VCAM-1 Surpass Conventional Metrics in Identifying Nephritis Disease Activity in Childhood-Onset Systemic Lupus Erythematosus.
    Soliman SA; Haque A; Vanarsa K; Zhang T; Ismail F; Lee KH; Pedroza C; Greenbaum LA; Mason S; Hicks MJ; Wenderfer SE; Mohan C
    Front Immunol; 2022; 13():885307. PubMed ID: 35720325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of urinary transferrin and ceruloplasmin in patients with systemic lupus erythematosus for differentiating patients with lupus nephritis.
    Urrego T; Ortiz-Reyes B; Vanegas-García AL; Muñoz CH; González LA; Vásquez G; Gómez-Puerta JA
    Reumatol Clin (Engl Ed); 2020; 16(1):17-23. PubMed ID: 29530762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.